MedTrace Logo

A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis

NCT03880266 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2021-08-25

Study results available
· View outcomes & findings →

Summary

The objective of this study is to assess the efficacy and safety of glycopyrronium cloth, 2.4% when used to treat palmar hyperhidrosis.

Conditions

  • Palmar Hyperhidrosis

Interventions

DRUG

Glycopyrronium cloth, 2.4%

Pre-saturated 100% polypropylene, nonwoven, fabric cloth with glycopyrronium

DRUG

Vehicle

Pre-saturated 100% polypropylene, nonwoven, fabric cloth

Sponsors & Collaborators

  • Journey Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Kate Doherty · Dermira, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-22
Primary Completion
2019-05-24
Completion
2019-05-24
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03880266 on ClinicalTrials.gov